Motivation: Small p-values are often required to be accurately estimated in large scale genomic studies for the adjustment of multiple hypothesis tests and the ranking of genomic features based on their statistical significance. For those complicated test statistics whose cumulative distribution functions are analytically intractable, existing methods usually do not work well with small p-values due to lack of accuracy or computational restrictions.
INTRODUCTION
P-value is the most widely used metric to access the statistical significance of genomic features in large-scale genomic studies such as genome-wide association studies (GWAS) and high-throughput differential gene expression analysis. In those studies, very small pvalues are often required to be accurately calculated, because: (1) A large number of tests are often performed in those studies and most of the methods used for multiple comparison adjustment in genomic studies, such as the Bonferroni correction for family-wise error rate and the Benjamini-Hochberg procedure for controlling false discovery rate (Benjamini and Hochberg, 1995) , work directly on the p-values associated with the genomic features.
Therefore, it is essential to accurately evaluate p-values at very small scales so that those procedures are reliable. (2) In practice, it is desirable to rank the significant genomic features by their p-values (often together with their effect sizes) so that the researchers can prioritize and follow up with those significant genomic features for further biological studies, which also requires that the small p-values associated with those features to be accurately estimated. In the literature, it is not uncommon to see that very small p-values associated with the most significant genomic features to the order of less than 10 -100 are reported [e.g. (Burton, et al., 2007) and (Cauchi, et al., 2007) . More examples can be found in (Bangalore, et al., 2009) ].
Problem formulation
The problem addressed in this work is how to estimate small p-values for a group of complicated test statistics whose cumulative distribution functions (CDF) are analytically intractable. Specifically, the question can be formulated as follows: the goal is to estimate the p-value defined as
where Y is the data or transformed data that follow some probability distribution (e.g.
multivariate normal distribution), T(Y)
is the test statistic which is a function of Y, q is the test statistic calculated based on the observed data that can be either a scalar or a vector, and H0 means that the probability is obtained under the null hypothesis, which will be dropped for simplicity hereafter. In most commonly used test procedures (e.g. two-sample
t-test), the p-values are obtained by deriving the exact or asymptotic distributions of T(Y)
under H0. However, the problem we often encounter is that T(Y) is complicated whose CDF under H0 cannot be derived analytically, and existing approaches do not work for estimating very small p-values either due to lack of accuracy or unaffordable computational 4 burden.
We illustrate this problem with the following three real world examples in genomic studies.
Example 1: Gene set/pathway enrichment analysis.
Here the goal is to test the significance of the association between some clinical outcomes of interest and the global expression pattern of a gene set or pathway (for brevity, gene set will be used hereafter), where gene sets are pre-specified groups of genes according to the biological functions or genomic locations of the genes. For a study with n independent subjects and a gene set with q genes, Goeman et al proposed to fit the following model,
where y is the n × 1 outcome vector, Z is an n × q the expression matrix of the q genes in n subjects, X is an n × p matrix for the p covariates that needs to be adjusted, g is the canonical link function for the distribution of y (e.g. g is the identity function for normal distributed data or the logistic function for binomial distributed data), and α and β are the corresponding vectors of coefficients. The association between Z and outcome y can be assessed by testing the null hypothesis 0 : H = β 0 using the following test statistic
where μ is the expectation of y under H0 (Goeman, et al., 2004; Goeman, et al., 2011) . A similar approach is also proposed in (Liu, et al., 2007) , where the matrix
is replaced by a kernel function to account for the interaction of genes in the same gene set.
Example 2: GWAS -joint testing a group of genetic markers in a genomic region
To increase the power of GWAS, approaches for joint testing a group of genetic markers (SNPs) in a genomic region instead of testing individual genetic markers are developed.
Wu et al proposed an approach under similar framework as in Example 1, and the following model is fit
where y is the n × 1 phenotype vector, G is an n × q genotype matrix for the q SNPs in the genomic region that need to be tested, X is an n × p matrix for the p covariates that needs to be adjusted, g is the canonical link function for the distribution of y, and α and β are the vectors of coefficients. The association between G and phenotype y can be assessed by testing the null hypothesis 0 :
where μ is the expectation of y under H0 and W is a diagonal matrix containing the weights of the q SNPs (Wu, et al., 2011) . If the weight of each SNP is 1, then 2 Q is the same as 1 Q in Example 1 up to a constant. Similarly, the matrix T G WG can be replaced by a kernel matrix to account for the epistatic effects of the SNPs (Wu, et al., 2011) .
Example 3: Ratio statistics in differential gene expression analysis
Consider the differential expression analysis comparing two groups of gene expression data.
For a gene g to be tested, let xg1 and xg2 be the vectors of positive normalized gene expression values respectively for the two groups with sample sizes n1 and n2. The following ratio statistic (a.k.a. fold change or proportion statistic) has been proposed to test the differential expression of g between the two groups (Segal, et al., 2017) ,
where 1 y and 2 y are the respective sample means of the two groups. Note that the p-value computed based on the test statistic (6) is the two-sided p-value based on the test statistic, 1 2 / y y (Segal, et al., 2017) . Without loss of generality and for the ease of derivation, we will assume 1 2 y y ≥ and use the test statistic,
in the following discussions. Other approaches for testing differential gene expression based on the ratio statistics are also proposed in (Newton, et al., 2001; Chen, et al., 2002; Bergemann and Wilson, 2011 
where Y follows a multivariate normal (MVN) distribution either exactly if the outcome or phenotype data y is assumed to follow normal distributions or asymptotically if y is assumed to follow binomial distributions, and D is a diagonal matrix containing the positive eigenvalues of
See for σ are the population mean and variance under the null hypothesis that there is no differential expression between the two groups.
Related literature
In the literature, the quadratic form statistics (8), a.k.a. a linear combination or weighted sum of chi-squared random variables (Bausch, 2013) , are used for testing the associations between genomic features and the outcomes or phenotypes under several settings in genomic studies. A few methods are proposed specifically to calculate the tail probabilities for this form of statistic Liu, et al., 2009 ).
See for comparisons of them and (Bausch, 2013) for a review. As commented in (Bausch, 2013) In this paper, we propose a general approach for accurately and efficiently estimating small to extremely small p-values for any test statistic that can be expressed in the form (1).
The basis of our approach contains two components. The first component is the crossentropy (CE) method, which is originated from the concept of CE in information theory and has been widely used for rare event simulation in the operations research field . The second component is Markov chain Monte Carlo (MCMC) sampling techniques. Therefore, we refer our approach as MCMC-CE algorithm hereafter. The rest of this paper is organized as follows. In the next section, we give a general introduction of the CE method and MCMC techniques used in our approach, and then present our algorithm for estimating small p-values. In Section 3, we evaluate the performance of the proposed algorithm by comparing it with several existing approaches through simulations and demonstrate its applications with three genomic datasets.
Discussions are given in Section 4.
METHODS

The CE method
Our goal is to calculate the p-value as expressed in Eq. (1), which can be further written as
where the subscript θ0 denotes the parameter vector of the probability distribution that Y follows under H0 [e.g. it is an MVN distribution in the above three examples. We use 0 ( ; ) f ⋅ θ to denote this distribution hereafter], and the expectation is taken with respect to 0 ( ; ) f ⋅ θ with ( ) I ⋅ as the indicator function.
As discussed above, when p is small, using the brute-force MC method is computationally inefficient. The CE method is a general approach for the efficient estimation of small probabilities in MC simulations, which we briefly introduce below following the monograph on CE method . The technique used in the CE method is importance sampling (IS). Let ( ) g ⋅ be the proposal density function used in IS, then the expectation in Eq. (10) can be re-expressed as 0 0
where the subscript g denotes that the expectation is taken with respect to ( ) g ⋅ now. Then p can be estimated by the MC counterpart (a.k.a. stochastic counterpart) of (11),
where yl's, l = 1, ..., N are random samples drawn from ( ) g ⋅ now. There is an optimal proposal density under which the IS estimator (12) has zero MC sampling variance , which is given by
However, * g cannot be directly used as the proposal density for estimating p in IS, since it contains the unknown probability p that is the quantity we want to calculate. The CE method provides a general solution to finding a proposal density ( ; ) f ⋅ θ which is close to the optimal proposal density * g within the same distribution family as 0 ( ; ) f ⋅ θ in the sense that the Kullback-Leibler divergence [a.k.a the Kullback-Leibler cross-entropy or cross-entropy ] between ( ; ) f ⋅ θ and * g is minimized:
( )
where ( One of the major limitations of the multi-level CE algorithm is that it is unreliable in high-dimensional settings, i.e. when the dimension of θ is large. With recent progress in MCMC sampling techniques, here we apply and implement an improved version of CE method based on the theoretical work in ) that combines the CE criterion (14) and MCMC techniques. Observe that the second term in the r.h.s. of the second equality in (14) can be written as
where the subscript 
Sampling from the optimal proposal density
Here we discuss the algorithms for sampling from Table 1 summarizes four of them. The Gibbs sampler is a classical MCMC method for sampling from truncated distributions that consecutively draws samples from a sequence of conditional distributions (Geweke, 1991; Kotecha and Djuric, 1999) . The hit-and-run sampler belongs to the class of line samplers, which reduces the problem of sampling from a multivariate constrained distribution to that of sampling from a univariate truncated distribution (Chen and Schmeiser, 1993; Kroese, et al., 2011) . The Hamiltonian and Lagrangian Monte Carlo samplers are two more recently developed powerful tools for sampling from many complicated distributions, which respectively use the principles of the Hamiltonian and Lagrangian dynamics in physics (Pakman and Paninski, 2014; Lan, et al., 2015) . In our empirical comparisons, we find that the Gibbs sampler is more efficient for sampling from a truncated distribution with linear constraints such as Example 3, while Hamiltonian and Lagrangian Monte Carlo samplers are more efficient for sampling from a truncated distribution with quadratic constraints such as Example 1 and 2 (not shown here). Table 1 . Algorithms for sampling from the optimal proposal distribution
Algorithm Reference
Gibbs sampler (Geweke, 1991; Kotecha and Djuric, 1999) Hit-and-run sampler (Chen and Schmeiser, 1993; Kroese, et al., 2011 ) Hamiltonian Monte Carlo sampler (Brubaker, et al., 2012; Pakman and Paninski, 2014) Lagrangian Monte Carlo sampler (Lan, et al., 2015) 
The MCMC-CE algorithm for calculating small p-values
Combining the above discussions, our algorithm for calculating the small p-value
contains two steps: in the first step we draw random samples from * g and solve the maximization problem (16), and in the second step we estimate p using regular IS with ( ; ) f ⋅ θ as the proposal density. The algorithm is summarized as follows:
Algorithm (MCMC-CE method for estimating small p-values)
A. Parameters updating step:
1. Draw N random samples 1 ,..., N y y from * g using an efficient MCMC sampling algorithm (as shown in Table 1 ).
2. Solve the maximization problem (16) and obtain the CE optimal proposal density
B. Estimating step: ), Farebrother's method , and
RESULTS
Simulation studies
Imhof's method -100 with less than 3% relative errors.
Application to genomic data analysis
We apply MCMC-CE to the estimation of small p-values in three real world examples from genomic studies.
We apply MCMC-CE to a dataset containing gene expression measurements and clinical variables of melanoma patients, which is part of The Cancer Genome Atlas (TCGA) project and publicly available from TCGA data portal: https://portal.gdc.cancer.gov/.
Particularly, the dataset contains the expression levels of 20531 genes from 355 melanoma patients measured by RNA-Seq, and we are interested in testing which gene sets are associated with the clinical variable of interest, Breslow thickness. The gene set annotations are extracted from the Gene Ontology Consortium (Ashburner, et al., 2000; Gene Ontology Consortium, 2017) , where 22211 gene sets are curated. For each gene set, model (2) is fitted with log transformed Breslow thickness as the outcome variable and gender and age as the adjusted covariates. Since the computational time will be overwhelming if all the 22211 gene sets are to be tested using MCMC-CE and our purpose is to demonstrate the strength of MCMC-CE, we first do the following screening test to filter out those lesssignificant gene sets: we calculate the approximated p-values for all the gene sets using the method implementing in the globaltest package (Goeman, et al., 2004) Table   S6 .
Example 2: GWAS -joint testing a group of genetic markers in a genomic region
We demonstrate the application of MCMC-CE in testing groups of SNPs in GWAS.
The dataset used is collected in a GWAS performed in the population of about 2000 heterogeneous stock mice phenotyped for over 100 traits (Valdar, et al., 2006) (Valdar, et al., 2006) . A complete list of SNP groups tested is presented in Table S7 .
Example 3: Ratio statistic in differential gene expression analysis
We demonstrate the application of MCMC-CE in estimating small p-values based on the ratio statistic (6) in differential gene expression analysis and how MCMC-CE can be used to access the genome-wide significance after the adjustment of multiple comparisons.
The dataset used is from a study on patients who were diagnosed with salivary adenoid cystic carcinoma and received radiation therapy, and the expression levels of 22243 genes in the salivary gland tissues of those patients were measured by RNA-Seq. The details of the study can be found in (Brayer, et al., 2016) and the sequencing read data are available from the NCBI Sequence Read Archive using accession number SRP059557. The dataset used consists of 14 patients, where 8 were free of cancer and 6 relapsed at the end of the study, and here we are interested in testing genes differentially expressed between those two groups of patients. After filtering out lowly expressed genes, 11390 genes are left and the gene count data are normalized using the trimmed mean of M-values method implemented in R package edgeR (Robinson, et al., 2010) and log-transformed counts per million (CPM) values are used for our analysis.
The following methods for estimating the p-values based on the ratio statistic are included in our comparisons:
(1) A brute-force MC method: for each gene, the two-sided p-value is computed as For all the above methods, we use the Benjamini-Hochberg procedure (Benjamini and Hochberg, 1995) to control the FDR given the p-values computed by each method. As a comparison, we also run the differential expression analysis using samr package with its default settings (Tusher, et al., 2001) . Table 4 presents the numbers of significant differentially expressed genes identified by each method with different FDR threshold values, and Supplemental Table S8 shows the detailed results. We can see that the bruteforce MC method suffers the issue that the results with more stringent FDR thresholds are not reliable (Table 4, Table S8 ). We also illustrate the application of MCMC-CE for differential expression analysis in a microarray dataset with larger sample size and more extreme p-values, which Pakman and Paninski, 2013) . Therefore, it can help researchers develop new test procedures in genomic studies.
The implementation of the algorithm can be further optimized. For instance, throughout all the simulations and applications in this paper we simply repeat the algorithm 100 times by drawing N = 10000 random samples in the parameter updating step and M = 10000 importance samples in the estimating step (see the algorithm in Section 2.3). The number of repetitions and random samples can be further optimized which can make the algorithm even faster. In addition, systematic evaluations of the performance of those MCMC techniques (Table 1) for sampling from truncated distributions will be informative for the application of our proposed algorithm. Those are considered as our future work.
Review of the multi-level CE method
For a complete introduction of the CE method, here we briefly review the multi-level CE method, which is an earlier alternative to the MCMC-CE method presented in the main text. Our goal is to find θ that maximize the second term in the r.h.s. of the second equality in Eq. (14) 
Simulation studies
We perform simulations to evaluate the performance of MCMC-CE algorithm. Since the tail probabilities of some functions of the multivariate normal variables can be calculated analytically (e.g. the sum of squares of independent standard normal variables is chisquared distribution) and several methods are developed specifically for calculating the tail probabilities of the quadratic form of MVN variables, our numerical experiments below
where Y is a MVN random variable, so that we can obtain the errors and variations of MCMC-CE.
Quadratic function of MVN variables
Here we use MCMC-CE to evaluate the small tail probabilities of quadratic form of MVN variables and compare it with several approaches specific for calculating the tail probabilities of this form of statistic, including Davies' method (Davies, 1980 ), Farebrother's method , and Imhof's method , which are all implemented in the R package CompQuadForm Supplementary Table S3 and  in Supplementary Table S4) .
Ratio of normal variables
Here we use MCMC-CE to calculate the small tail probabilities of the ratio of two Specifically, the ratio of two independent standard normal variables follows the standard Cauchy distribution, whose true tail probabilities are available in most statistical packages (e.g. it can be calculated from the pcauchy function in R). Therefore, our simulations here are based on the ratio of two independent standard normal variables so that we can evaluate the errors and variations of MCMC-CE. With the standard Cauchy distribution, we use a sequence of q's and obtain the values of p on orders ranging from 10 -6 to 10 -100 , and we use MCMC-CE to calculate p's and the errors. Here we generate N = 10 4 random samples in the parameters updating step using the Gibbs sampler, which we find is much faster than other MCMC samplers ( Table S5 ).
Additional real-world example
Similar to Example 3 in the main text, here we demonstrate the application of MCMC-CE in estimating small p-values based on the ratio statistic in differential expression analysis with a microarray gene expression dataset. The dataset used is published in (Golub, et al., 1999) and available from bioconductor as the golubEsets package. It contains 38 leukemia patients with 27 acute lymphoblastic leukemia (ALL) patients and 11 acute myeloid leukemia (AML) patients for which the expression levels of 7129 genes are measured. We are interested in testing which genes are differentially expressed between ALL and AML patients. We first perform normalization and variance stabilizing transformation of the data using the package vsn (Huber, et al., 2002) , and then carry out the differential expression analysis with the same methods as described in Example 3 in the main text (i.e. Brute-force MC, MCMC-CE, Perm0, Perm1 and samr). Except that the numbers of permutations are set as 10 5 for Perm0 and Perm1, the other settings for those methods are the same as described Example 3 in the main text. 
List of supplementary tables
Those tables can be viewed by Microsoft Excel software. 
